Biosimilars Market Size, Share & Trends Report

Biosimilars Market Size, Share & Trends Analysis Report By Product, By Application (Oncology, Growth Hormone, Blood Disorders, Chronic & Autoimmune Disorders), By Region, And Segment Forecasts, 2020 - 2025

Report ID: 978-1-68038-916-6
Number of Pages: 70
Format: Electronic (PDF)

Historical Range: 2014 - 2018
Industry:Healthcare

Market Segmentation

Biosimilars ProductOutlook (Revenue, USD Million, 2014 - 2025)
- Recombinant non-glycosylated proteins
  - Human growth hormones
  - Granulocyte colony-stimulating factor
  - Interferons
  - Insulin
- Recombinant glycosylated proteins
  - Erythropoietin
  - Monoclonal antibodies
  - Follitropin
Biosimilars Application Outlook (Revenue, USD Million, 2014 - 2025)
- Oncology
- Blood disorders
- Growth hormonal deficiency
- 慢性和自身免疫性疾病
- Others
Biosimilars Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
  - The U.S.
    - The U.S. Biosimilars Market, By Product
      - Recombinant non-glycosylated proteins
        
        Human growth hormones
        
        Granulocyte colony-stimulating factor
        
        Interferons
        
        Insulin
      - Recombinant glycosylated proteins
        
        Erythropoietin
        
        Monoclonal antibodies
        
        Follitropin
    - The U.S. Biosimilars Market, By Application
      - Oncology
      - Blood disorders
      - Growth hormonal deficiency
      - 慢性和自身免疫性疾病
      - Others
  - Canada
    - Canada Biosimilars Market, By Product
      - Recombinant non-glycosylated proteins
        
        Human growth hormones
        
        Granulocyte colony-stimulating factor
        
        Interferons
        
        Insulin
      - Recombinant glycosylated proteins
        
        Erythropoietin
        
        Monoclonal antibodies
        
        Follitropin
    - Canada Biosimilars Market, By Application
      - Oncology
      - Blood disorders
      - Growth hormonal deficiency
      - 慢性和自身免疫性疾病
      - Others
- Europe
  - Germany
    - Germany Biosimilars Market, By Product
      - Recombinant non-glycosylated proteins
        
        Human growth hormones
        
        Granulocyte colony-stimulating factor
        
        Interferons
        
        Insulin
      - Recombinant glycosylated proteins
        
        Erythropoietin
        
        Monoclonal antibodies
        
        Follitropin
    - Germany Biosimilars Market, By Application
      - Oncology
      - Blood disorders
      - Growth hormonal deficiency
      - 慢性和自身免疫性疾病
      - Others
  - The U.K.
    - The U.K. Biosimilars Market, By Product
      - Recombinant non-glycosylated proteins
        
        Human growth hormones
        
        Granulocyte colony-stimulating factor
        
        Interferons
        
        Insulin
      - Recombinant glycosylated proteins
        
        Erythropoietin
        
        Monoclonal antibodies
        
        Follitropin
    - The U.K. Biosimilars Market, By Application
      - Oncology
      - Blood disorders
      - Growth hormonal deficiency
      - 慢性和自身免疫性疾病
      - Others
- Asia Pacific
  - China
    - China Biosimilars Market, By Product
      - Recombinant non-glycosylated proteins
        
        Human growth hormones
        
        Granulocyte colony-stimulating factor
        
        Interferons
        
        Insulin
      - Recombinant glycosylated proteins
        
        Erythropoietin
        
        Monoclonal antibodies
        
        Follitropin
    - China Biosimilars Market, By Application
      - Oncology
      - Blood disorders
      - Growth hormonal deficiency
      - 慢性和自身免疫性疾病
      - Others
  - India
    - India Biosimilars Market, By Product
      - Recombinant non-glycosylated proteins
        
        Human growth hormones
        
        Granulocyte colony-stimulating factor
        
        Interferons
        
        Insulin
      - Recombinant glycosylated proteins
        
        Erythropoietin
        
        Monoclonal antibodies
        
        Follitropin
    - India Biosimilars Market, By Application
      - Oncology
      - Blood disorders
      - Growth hormonal deficiency
      - 慢性和自身免疫性疾病
      - Others
- RoW
  - RoW Biosimilars Market, By Product
    - Recombinant non-glycosylated proteins
      - Human growth hormones
      - Granulocyte colony-stimulating factor
      - Interferons
      - Insulin
    - Recombinant glycosylated proteins
      - Erythropoietin
      - Monoclonal antibodies
      - Follitropin
  - RoW Biosimilars Market, By Application
    - Oncology
    - Blood disorders
    - Growth hormonal deficiency
    - 慢性和自身免疫性疾病

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
乐鱼体育手机网站入口
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2014 to 2025
Market estimates and forecast for product segments up to 2025
Regional market size and forecast for product segments up to 2025
Market estimates and forecast for application segments up to 2025
Regional market size and forecast for application segments up to 2025
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report -free of charge- including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read ourprivacy policy.